Showing results (261-270 of 275) with videos related to
Sort By:
Pageof 28
Open Forum Infectious Diseases|March 24, 2025
Demographic and Clinical Factors Associated With SARS-CoV-2 Anti-Nucleocapsid Antibody Response Among Previously Infected US Adults: The C4R StudyRyan T Demmer, Chaoqi Wu, John S Kim, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 4, 2017
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with AgeW Gerald Teague, Brenda R Phillips, John V Fahy, et al.American Journal of Respiratory and Critical Care Medicine|August 25, 2016
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent ExacerbationsLoren C Denlinger, Brenda R Phillips, Sima Ramratnam, et al.Journal of Biopharmaceutical Statistics|September 17, 2020
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerationsAnastasia Ivanova, Elliot Israel, Lisa M LaVange, et al.Genome Medicine|April 22, 2021
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epitheliumSilva Kasela, Victor E Ortega, Molly Martorella, et al.JAMA Network Open|June 17, 2024
Epidemiologic Features of Recovery From SARS-CoV-2 InfectionElizabeth C Oelsner, Yifei Sun, Pallavi P Balte, et al.The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.The Journal of Allergy and Clinical Immunology|March 5, 2021
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainmentElliot Israel, Loren C Denlinger, Leonard B Bacharier, et al.The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.Plos One|February 10, 2025
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R studyElizabeth C Oelsner, Akshaya Krishnaswamy, Rafail Rustamov, et al.Pageof 28